Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

35.96
Delayed Data
As of Sep 22
 -0.01 / -0.03%
Today’s Change
29.83
Today|||52-Week Range
36.21
+10.71%
Year-to-Date
Pfizer-Merck KGaA Skin Cancer Drug Bavencio Gets EU Approval
Sep 22 / Zacks.com - Paid Partner Content
Stock Market News For Sep 21, 2017
Sep 21 / Zacks.com - Paid Partner Content
Dow 30 Stock Roundup: BA Wins $600M Air Force Contract, JPM Invests in Bill.com
Sep 22 / Zacks.com - Paid Partner Content
Can Pfizer (PFE) Prove to be an Apt Value Investment?
Sep 21 / Zacks.com - Paid Partner Content
Cancer Space Update: Mixed Week for Pfizer, Roche Falters
Sep 22 / Zacks.com - Paid Partner Content
Mylan Down 24% Year to Date: What's Troubling the Stock?
Sep 20 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Pfizer Files Suit against J&J, Supernus Hit by Study Update
Sep 22 / Zacks.com - Paid Partner Content
US Market Indexes Gain on Wednesday
Sep 20 / GuruFocus News - Paid Partner Content
Pfizer Sues J&J, Accuses it of Preventing Inflectra Uptake
Sep 21 / Zacks.com - Paid Partner Content
Pfizer takes on J&J with antitrust lawsuit
Sep 20 / FT.com - Paid Partner Content

Today’s Trading

Previous close35.97
Today’s open36.10
Day’s range35.77 - 36.12
Volume14,605,376
Average volume (3 months)18,882,092
Market cap$214.1B
Dividend yield3.56%
Data as of 4:00pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)+5.09%
Earnings growth (this year)+6.73%
Earnings growth (next 5 years)+5.75%
Revenue growth (last year)+8.13%
P/E ratio26.2
Price/Sales3.79
Price/Book3.67

Competitors

 Today’s
change
Today’s
% change
NVSNovartis+1.22+1.44%
MRKMerck-0.47-0.72%
SNYSanofi+0.39+0.78%
ABBVAbbVie+0.07+0.08%
Data as of 4:02pm ET, 09/22/2017

Financials

Next reporting dateOctober 31, 2017
EPS forecast (this quarter)$0.64
Annual revenue (last year)$52.8B
Annual profit (last year)$7.2B
Net profit margin13.63%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Ian C. Read
Chief Financial Officer &
EVP-Business Operations
Frank A. D'Amelio
Corporate headquarters
New York, New York

Forecasts